Neuberger Berman Group Portfolio holdings
AUM
$130B
1-Year Return
22.03%
This Quarter Return
+2.42%
1 Year Return
+22.03%
3 Year Return
+86.29%
5 Year Return
+159.6%
10 Year Return
+388.21%
AUM
$126B
AUM Growth
-$2.19B
(-1.7%)
Cap. Flow
-$1.87B
Cap. Flow
% of AUM
-1.48%
Top 10 Holdings %
Top 10 Hldgs %
20.37%
Holding
2,026
New
102
Increased
817
Reduced
889
Closed
102
Top Buys
| 1 |
Accenture
ACN
|
+$300M |
| 2 |
Medtronic
MDT
|
+$196M |
| 3 |
Chevron
CVX
|
+$190M |
| 4 |
Wells Fargo
WFC
|
+$178M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| 1 |
Procter & Gamble
PG
|
+$303M |
| 2 |
Becton Dickinson
BDX
|
+$243M |
| 3 |
Pfizer
PFE
|
+$239M |
| 4 |
Keurig Dr Pepper
KDP
|
+$236M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$208M |
Sector Composition
| 1 | Technology | 27.05% |
| 2 | Financials | 14.4% |
| 3 | Industrials | 12.06% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Healthcare | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Eastman Chemical
EMN
$7.8B
| $1.17M | ﹤0.01% |
12,846
-849
| -6% | -$77.5K |
|
1252
Pilgrim's Pride
PPC
$10.5B
| $1.17M | ﹤0.01% |
25,748
-588
| -2% | -$26.7K |
|
1253
PPL Corp
PPL
$26.6B
| $1.16M | ﹤0.01% |
35,867
+5,072
| +16% | +$165K |
|
1254
Lantheus
LNTH
$3.74B
| $1.16M | ﹤0.01% |
12,988
-65,730
| -84% | -$5.88M |
|
1255
U-Haul Holding Co Series N
UHAL.B
$10B
| $1.16M | ﹤0.01% |
18,053
+192
| +1% | +$12.3K |
|
1256
Janus Henderson
JHG
$7.08B
| $1.15M | ﹤0.01% |
27,139
+7,461
| +38% | +$317K |
|
1257
Dr. Reddy's Laboratories
RDY
$12.3B
| $1.15M | ﹤0.01% |
72,999
-1,616
| -2% | -$25.5K |
|
1258
News Corp Class A
NWSA
$16.6B
| $1.15M | ﹤0.01% |
41,793
+95
| +0.2% | +$2.62K |
|
1259
Lennox International
LII
$19.9B
| $1.15M | ﹤0.01% |
1,887
-2
| -0.1% | -$1.22K |
|
1260
iShares Core US REIT ETF
USRT
$3.17B
| $1.15M | ﹤0.01% |
+20,000
| New | +$1.15M |
|
1261
Old Republic International
ORI
$10.1B
| $1.15M | ﹤0.01% |
31,665
-6,459
| -17% | -$234K |
|
1262
CMS Energy
CMS
$21.5B
| $1.14M | ﹤0.01% |
17,177
+454
| +3% | +$30.3K |
|
1263
Organon & Co
OGN
$2.77B
| $1.14M | ﹤0.01% |
76,670
-7,566
| -9% | -$113K |
|
1264
Vanguard Health Care ETF
VHT
$15.9B
| $1.14M | ﹤0.01% |
4,506
-142
| -3% | -$36K |
|
1265
GSK
GSK
$83.5B
| $1.14M | ﹤0.01% |
33,676
-129
| -0.4% | -$4.36K |
|
1266
Invesco
IVZ
$10.1B
| $1.14M | ﹤0.01% |
64,935
-1,336
| -2% | -$23.4K |
|
1267
United Therapeutics
UTHR
$18.3B
| $1.13M | ﹤0.01% |
3,214
+44
| +1% | +$15.5K |
|
1268
iShares Global Infrastructure ETF
IGF
$8.2B
| $1.13M | ﹤0.01% |
21,658
+15,800
| +270% | +$826K |
|
1269
C.H. Robinson
CHRW
$15.5B
| $1.13M | ﹤0.01% |
10,935
+5
| +0% | +$517 |
|
1270
Vanguard FTSE Developed Markets ETF
VEA
$175B
| $1.13M | ﹤0.01% |
23,589
-6,497
| -22% | -$311K |
|
1271
Stifel
SF
$11.8B
| $1.12M | ﹤0.01% |
10,523
+36
| +0.3% | +$3.82K |
|
1272
Jazz Pharmaceuticals
JAZZ
$7.79B
| $1.11M | ﹤0.01% |
8,990
-357
| -4% | -$44K |
|
|
NBGR
1273
DELISTED
Neuberger Berman Global Real Estate ETF
NBGR
| $1.11M | ﹤0.01% |
42,732
| – | – |
|
1274
Rivian
RIVN
$17B
| $1.1M | ﹤0.01% |
83,082
-1,361
| -2% | -$18.1K |
|
1275
Endava
DAVA
$543M
| $1.1M | ﹤0.01% |
35,572
-7,863
| -18% | -$243K |
|